Examples of using Single subcutaneous injection in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
minor soft tissue surgery: single subcutaneous injection before surgery, for example at the time of induction of anaesthesia.
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight(i.e. 0.04 ml/kg body weight) before surgery, for example at the time of induction of anaesthesia.
Elonva should be administered as a single subcutaneous injection, preferably in the abdominal wall,
minor soft tissue surgery: single subcutaneous injection before surgery, for example at the time of induction of anaesthesia.
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight(i.e. 0.4 ml/10 kg body weight).
Cattle: Single subcutaneous injection at a dosage of 0.5 mg meloxicam/kg body weight i.e.
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight(i.e. 0.4 ml/10 kg body weight).
The recommended dose of Prolia is 60 mg administered as a single subcutaneous injection once every 6 months into the thigh, abdomen or upper arm.
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight(i.e. 0.1 ml/kg body weight) before surgery, for example at the time of induction of anaesthesia.
After a single subcutaneous injection of Elonva, the maximum serum concentration of corifollitropin alfa is 4.24 ng/mL(2.49-7.21 ng/mL1) and is reached 44 hours(35-57 hours1) postdose.
Following a single subcutaneous injection of 100 mg, the absorption of golimumab was similar in the upper arm,
After a single subcutaneous injection of 6 mg lipegfilgrastim during the fourth cycle, the maximum blood
After a single subcutaneous injection of 6 mg lipegfilgrastim during the fourth cycle,
sustain multiple follicular growth for an entire week, a single subcutaneous injection of the recommended dose of Elonva may replace the first seven injections of any daily(rec)FSH preparation in a COS treatment cycle.
dialysis is 1.2 microgram/kg body weight, administered once every month as a single subcutaneous injection.
subacute inflammation after single subcutaneous injection or mild inflammatory
the average terminal half-life ranged from approximately 32 to 62 hours after a single subcutaneous injection of 6 mg lipegfilgrastim.
The recommended dose of XGEVA for the treatment of giant cell tumour of bone is 120 mg administered as a single subcutaneous injection once every 4 weeks into the thigh, abdomen or upper arm with additional 120 mg doses on days 8 and 15 of treatment of the first month of therapy.
In calves, a single subcutaneous injection of 10 times the recommended dose(40 mg/kg body weight)
the mean terminal half-life was approximately 28 hours after a single subcutaneous injection of 6 mg lipegfilgrastim during the first cycle of chemotherapy.